|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 170.93 USD | +0.61% |
|
+10.66% | +16.61% |
| 09:02am | Rotation Tests Market Faith | |
| 06:31am | North American Morning Briefing : U.S. Futures Point to Gains As Iran Tensions Ease | DJ |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.56 | 3.56 | 3.85 | 4.93 | 5.31 | |||||
Return on Total Capital | 5.98 | 4.78 | 5.15 | 6.58 | 7.14 | |||||
Return On Equity % | 14.6 | 4.35 | 5.95 | 6.38 | 11.44 | |||||
Return on Common Equity | 17.76 | 6.57 | 7.48 | 8.07 | 12.97 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 41.51 | 36.85 | 36.85 | 37.7 | 39.95 | |||||
SG&A Margin | 16.52 | 17.79 | 16.77 | 16.69 | 18.9 | |||||
EBITDA Margin % | 21.84 | 16.67 | 17.62 | 19.47 | 19.49 | |||||
EBITA Margin % | 18.28 | 13.69 | 14.42 | 16.64 | 16.55 | |||||
EBIT Margin % | 15.28 | 11.31 | 12.22 | 14.74 | 15.22 | |||||
Income From Continuing Operations Margin % | 19.98 | 5.52 | 7.55 | 7.58 | 12.64 | |||||
Net Income Margin % | 20.99 | 7.3 | 8.38 | 8.5 | 13.06 | |||||
Net Avail. For Common Margin % | 20.96 | 7.26 | 8.35 | 8.47 | 12.99 | |||||
Normalized Net Income Margin | 17.79 | 10.31 | 7.88 | 9.5 | 11.22 | |||||
Levered Free Cash Flow Margin | 26.02 | 7.33 | 13.06 | 13.04 | 1.9 | |||||
Unlevered Free Cash Flow Margin | 26.41 | 7.69 | 13.49 | 13.57 | 2.5 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.48 | 0.5 | 0.5 | 0.54 | 0.56 | |||||
Fixed Assets Turnover | 4.01 | 3.64 | 3.45 | 3.65 | 3.95 | |||||
Receivables Turnover (Average Receivables) | 21.01 | 20.69 | 20.16 | 23.49 | 24.25 | |||||
Inventory Turnover (Average Inventory) | 19.64 | 18.59 | 18.71 | 21.71 | 26.98 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.7 | 1.66 | 1.81 | 1.79 | 1.55 | |||||
Quick Ratio | 1.43 | 1.37 | 1.53 | 1.52 | 1.16 | |||||
Operating Cash Flow to Current Liabilities | 0.61 | 0.37 | 0.52 | 0.43 | 0.38 | |||||
Days Sales Outstanding (Average Receivables) | 17.37 | 17.64 | 18.1 | 15.58 | 15.05 | |||||
Days Outstanding Inventory (Average Inventory) | 18.58 | 19.63 | 19.51 | 16.86 | 13.53 | |||||
Average Days Payable Outstanding | 68.16 | 68.01 | 70.25 | 75.72 | 76.05 | |||||
Cash Conversion Cycle (Average Days) | -32.21 | -30.74 | -32.64 | -43.28 | -47.47 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 16.74 | 16.32 | 17.42 | 18.48 | 22.76 | |||||
Total Debt / Total Capital | 14.34 | 14.03 | 14.83 | 15.6 | 18.54 | |||||
LT Debt/Equity | 15.13 | 15.04 | 15.82 | 15.35 | 20.33 | |||||
Long-Term Debt / Total Capital | 12.96 | 12.93 | 13.47 | 12.95 | 16.56 | |||||
Total Liabilities / Total Assets | 35.89 | 36.17 | 35.94 | 36.96 | 39.58 | |||||
EBIT / Interest Expense | 24.48 | 19.66 | 17.93 | 17.46 | 15.81 | |||||
EBITDA / Interest Expense | 36.53 | 31.21 | 27.69 | 24.49 | 21.38 | |||||
(EBITDA - Capex) / Interest Expense | 27.27 | 20.35 | 21.89 | 20.45 | 12.42 | |||||
Total Debt / EBITDA | 1.11 | 1.15 | 1.19 | 1.06 | 1.21 | |||||
Net Debt / EBITDA | -1.85 | -1.82 | -2.01 | -1.88 | -0.88 | |||||
Total Debt / (EBITDA - Capex) | 1.49 | 1.77 | 1.51 | 1.26 | 2.08 | |||||
Net Debt / (EBITDA - Capex) | -2.47 | -2.79 | -2.54 | -2.25 | -1.51 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 40.72 | 18.93 | 1.83 | 8.34 | 5.86 | |||||
Gross Profit, 1 Yr. Growth % | 29.47 | 5.57 | 1.83 | 10.85 | 12.18 | |||||
EBITDA, 1 Yr. Growth % | 13.72 | -9.22 | 5.88 | 19.02 | 5.96 | |||||
EBITA, 1 Yr. Growth % | 11.65 | -10.95 | 7.28 | 24.13 | 5.3 | |||||
EBIT, 1 Yr. Growth % | 14.72 | -11.95 | 9.97 | 29.63 | 9.35 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 2.09 | -67.14 | 39.28 | 8.78 | 76.61 | |||||
Net Income, 1 Yr. Growth % | 0.77 | -58.66 | 16.92 | 9.93 | 62.62 | |||||
Normalized Net Income, 1 Yr. Growth % | 13.7 | -31.07 | -22.19 | 29.61 | 24.98 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -2.22 | -58.42 | 20.77 | 13.79 | 71.52 | |||||
Accounts Receivable, 1 Yr. Growth % | 21.53 | 20.16 | -8.5 | -5.42 | 11.01 | |||||
Inventory, 1 Yr. Growth % | 87.48 | 8 | -5.12 | -10.81 | -25.82 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 58.97 | 13.86 | 1.44 | 3.4 | -7.45 | |||||
Total Assets, 1 Yr. Growth % | 28.73 | 0.32 | 3.39 | 0.67 | 2.23 | |||||
Tangible Book Value, 1 Yr. Growth % | 37.4 | 7.98 | 8.87 | 3.74 | 4.79 | |||||
Common Equity, 1 Yr. Growth % | 24.1 | 1.17 | 4.34 | -0.31 | 2.36 | |||||
Cash From Operations, 1 Yr. Growth % | 28.34 | -38.41 | 39.92 | -8.59 | -10.45 | |||||
Capital Expenditures, 1 Yr. Growth % | 27.34 | 28.61 | -35.6 | -6.53 | 167.93 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 63.61 | -66.5 | 81.5 | 7.64 | -84.56 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 61.48 | -65.37 | 78.65 | 8.48 | -80.46 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | 5.11 | 5.52 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 37.96 | 29.37 | 10.05 | 5.04 | 7.1 | |||||
Gross Profit, 2 Yr. CAGR % | 31.29 | 16.91 | 3.69 | 6.24 | 11.51 | |||||
EBITDA, 2 Yr. CAGR % | 26.09 | 1.61 | -1.42 | 12.58 | 12.63 | |||||
EBITA, 2 Yr. CAGR % | 25.14 | -0.29 | -2.26 | 15.81 | 14.73 | |||||
EBIT, 2 Yr. CAGR % | 33.38 | 0.5 | -1.6 | 19.9 | 19.56 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 33.63 | -42.08 | -32.35 | 23.09 | 38.61 | |||||
Net Income, 2 Yr. CAGR % | 30.89 | -35.46 | -30.48 | 13.37 | 33.7 | |||||
Normalized Net Income, 2 Yr. CAGR % | 34.08 | -11.47 | -26.76 | 0.83 | 27.79 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 28 | -36.24 | -29.14 | 17.22 | 39.7 | |||||
Accounts Receivable, 2 Yr. CAGR % | 32.86 | 20.85 | 4.86 | -6.97 | 2.46 | |||||
Inventory, 2 Yr. CAGR % | 80.68 | 42.3 | 1.23 | -8.01 | -18.66 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 54.42 | 34.53 | 7.47 | 2.42 | -2.18 | |||||
Total Assets, 2 Yr. CAGR % | 32.34 | 13.64 | 1.84 | 2.02 | 1.45 | |||||
Tangible Book Value, 2 Yr. CAGR % | 93.91 | 21.8 | 8.43 | 6.28 | 4.27 | |||||
Common Equity, 2 Yr. CAGR % | 38 | 12.05 | 2.75 | 1.99 | 1.02 | |||||
Cash From Operations, 2 Yr. CAGR % | 23.91 | -11.09 | -7.17 | 13.09 | -9.53 | |||||
Capital Expenditures, 2 Yr. CAGR % | 8.08 | 27.97 | -8.99 | -22.42 | 58.25 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 40.04 | -25.96 | -22.02 | 40.11 | -59.13 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 38.75 | -25.22 | -21.35 | 39.54 | -53.85 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | - | 5.32 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 42.05 | 31.3 | 19.45 | 9.48 | 5.31 | |||||
Gross Profit, 3 Yr. CAGR % | 27.39 | 22.08 | 11.65 | 6.02 | 8.19 | |||||
EBITDA, 3 Yr. CAGR % | 19.2 | 13.01 | 3.57 | 5.17 | 10.33 | |||||
EBITA, 3 Yr. CAGR % | 16.07 | 11.72 | 2.17 | 6.1 | 12.19 | |||||
EBIT, 3 Yr. CAGR % | 15.78 | 16.14 | 3.56 | 8.17 | 16.27 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 32.63 | -16.28 | -22.4 | -20.74 | 38.83 | |||||
Net Income, 3 Yr. CAGR % | 32.94 | -10.86 | -21.32 | -19 | 27.86 | |||||
Normalized Net Income, 3 Yr. CAGR % | 33.82 | 7.41 | -15.2 | -11.17 | 8.31 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 30.67 | -12.01 | -21.11 | -17.02 | 33.08 | |||||
Accounts Receivable, 3 Yr. CAGR % | 34.58 | 28.49 | 10.14 | 1.31 | -1.33 | |||||
Inventory, 3 Yr. CAGR % | 83.14 | 52.2 | 24.32 | -2.96 | -14.38 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 48.89 | 39.5 | 22.45 | 6.1 | -0.98 | |||||
Total Assets, 3 Yr. CAGR % | 33.08 | 20.67 | 10.11 | 1.45 | 2.09 | |||||
Tangible Book Value, 3 Yr. CAGR % | 50.95 | 59.53 | 17.33 | 6.84 | 5.78 | |||||
Common Equity, 3 Yr. CAGR % | 36.85 | 24.44 | 9.42 | 1.72 | 2.11 | |||||
Cash From Operations, 3 Yr. CAGR % | 22.59 | -1.85 | 3.42 | -7.64 | 4.63 | |||||
Capital Expenditures, 3 Yr. CAGR % | 28.3 | 14.53 | 1.79 | -8.18 | 17.27 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 27.66 | -13.06 | -0.17 | -13.04 | -32.82 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 27.25 | -12.65 | -0.04 | -12.31 | -27.54 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 47.96 | 40.06 | 28.26 | 20.09 | 14.34 | |||||
Gross Profit, 5 Yr. CAGR % | 34.85 | 25.83 | 17.32 | 15.48 | 11.6 | |||||
EBITDA, 5 Yr. CAGR % | 33.8 | 17.65 | 10.6 | 13.21 | 7.1 | |||||
EBITA, 5 Yr. CAGR % | 31.91 | 15.05 | 8.36 | 13.34 | 7.02 | |||||
EBIT, 5 Yr. CAGR % | 29.96 | 14.56 | 8.49 | 17.63 | 9.69 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.98 | 2.69 | 1.32 | -2.32 | -2.14 | |||||
Net Income, 5 Yr. CAGR % | 16.08 | 7.34 | 2.58 | -1.86 | -2.73 | |||||
Normalized Net Income, 5 Yr. CAGR % | 20.47 | 18.68 | 5.15 | 4.73 | -0.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 14.41 | 6.03 | 2.3 | -1.31 | -0.85 | |||||
Accounts Receivable, 5 Yr. CAGR % | 53.15 | 39.5 | 21.79 | 12.92 | 7.01 | |||||
Inventory, 5 Yr. CAGR % | - | 99.29 | 44.48 | 24.43 | 4.91 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 74.33 | 65.36 | 30.69 | 23.28 | 11.93 | |||||
Total Assets, 5 Yr. CAGR % | 35.93 | 27.32 | 19.57 | 12.83 | 6.56 | |||||
Tangible Book Value, 5 Yr. CAGR % | 35.19 | 35.72 | 32.24 | 35.61 | 11.92 | |||||
Common Equity, 5 Yr. CAGR % | 34 | 27.75 | 22.02 | 14.92 | 5.98 | |||||
Cash From Operations, 5 Yr. CAGR % | 32.46 | 11.5 | 9.69 | 3.88 | -1.97 | |||||
Capital Expenditures, 5 Yr. CAGR % | 30.76 | 37.1 | 11.83 | -1.99 | 21.44 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 37.94 | 0.88 | 4.81 | 5.22 | -30.16 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 37.47 | 1.29 | 4.97 | 5.35 | -26.62 |
- Stock Market
- Equities
- BABA Stock
- Financials Alibaba Group Holding Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















